Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma.

Juweid ME, Stroobants S, Hoekstra OS, Mottaghy FM, Dietlein M, Guermazi A, Wiseman GA, Kostakoglu L, Scheidhauer K, Buck A, Naumann R, Spaepen K, Hicks RJ, Weber WA, Reske SN, Schwaiger M, Schwartz LH, Zijlstra JM, Siegel BA, Cheson BD; Imaging Subcommittee of International Harmonization Project in Lymphoma.

J Clin Oncol. 2007 Feb 10;25(5):571-8. Epub 2007 Jan 22.

PMID:
17242397
2.

Aggressive and indolent non-Hodgkin's lymphoma: response assessment by integrated international workshop criteria.

Brepoels L, Stroobants S, De Wever W, Spaepen K, Vandenberghe P, Thomas J, Uyttebroeck A, Mortelmans L, De Wolf-Peeters C, Verhoef G.

Leuk Lymphoma. 2007 Aug;48(8):1522-30.

PMID:
17701583
3.

PET imaging for response assessment in lymphoma: potential and limitations.

Schöder H, Moskowitz C.

Radiol Clin North Am. 2008 Mar;46(2):225-41, viii. doi: 10.1016/j.rcl.2008.04.002. Review.

PMID:
18619378
4.
5.
6.

[18F-fluorodeoxyglucose positron emission tomography in the evaluation of therapy response assessment in lymphomas. Systematic literature review and meta-analysis].

Ramos-Font C, Rebollo Aguirre AC, Villegas Portero R, Romero Tabares A, Gallego Peinado M, Llamas Elvira JM.

Rev Esp Med Nucl. 2009 Mar-Apr;28(2):48-55. Review. Spanish.

7.

Positron emission tomography using F-18 fluorodeoxyglucose pre- and post-autologous stem cell transplant in non-Hodgkin's lymphoma.

Johnston PB, Wiseman GA, Micallef IN.

Bone Marrow Transplant. 2008 Jun;41(11):919-25. doi: 10.1038/bmt.2008.82. Epub 2008 Apr 7. Review.

PMID:
18391991
8.

PET and PET/CT for response evaluation in lymphoma: current practice and developments.

Brepoels L, Stroobants S, Verhoef G.

Leuk Lymphoma. 2007 Feb;48(2):270-82. Review.

PMID:
17325886
9.

[Application of 18F-FDG PET for the assessment of early response to the treatment and prognosis of patients].

Oriuchi N, Higuchi T, Endo K, Tsukamoto N, Matsuda H, Kuji I, Murakami K, Nakajima K.

Kaku Igaku. 2009 Jun;46(2):96-9. Japanese.

PMID:
19637820
10.

Revised response criteria for malignant lymphoma.

Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, Coiffier B, Fisher RI, Hagenbeek A, Zucca E, Rosen ST, Stroobants S, Lister TA, Hoppe RT, Dreyling M, Tobinai K, Vose JM, Connors JM, Federico M, Diehl V; International Harmonization Project on Lymphoma.

J Clin Oncol. 2007 Feb 10;25(5):579-86. Epub 2007 Jan 22.

11.

PET/CT for therapy response assessment in lymphoma.

Hutchings M, Barrington SF.

J Nucl Med. 2009 May;50 Suppl 1:21S-30S. doi: 10.2967/jnumed.108.057190. Epub 2009 Apr 20. Review.

12.

New staging and response criteria for non-Hodgkin lymphoma and Hodgkin lymphoma.

Cheson BD.

Radiol Clin North Am. 2008 Mar;46(2):213-23, vii. doi: 10.1016/j.rcl.2008.03.003.

PMID:
18619377
13.
14.

Evaluation of response to fractionated radioimmunotherapy with 90Y-epratuzumab in non-Hodgkin's lymphoma by 18F-fluorodeoxyglucose positron emission tomography.

Bodet-Milin C, Kraeber-Bodéré F, Dupas B, Morschhauser F, Gastinne T, Le Gouill S, Campion L, Harousseau JL, Wegener WA, Goldenberg DM, Huglo D.

Haematologica. 2008 Mar;93(3):390-7. doi: 10.3324/haematol.10591. Epub 2008 Feb 11.

15.

Hodgkin lymphoma: Response assessment by revised International Workshop Criteria.

Brepoels L, Stroobants S, De Wever W, Spaepen K, Vandenberghe P, Thomas J, Uyttebroeck A, Mortelmans L, De Wolf-Peeters C, Verhoef G.

Leuk Lymphoma. 2007 Aug;48(8):1539-47.

PMID:
17701585
16.

Diagnostic accuracy of 18F-2-deoxy-fluoro-D-glucose positron emission tomography for pN1 lymph nodes in patients with lung cancer.

Nakagawa M, Hara M, Sakurai K, Ozawa Y, Mizuno A, Tamaki T, Nishio M, Shibamoto Y.

Acta Radiol. 2009 Jul;50(6):638-44. doi: 10.1080/02841850902971255.

PMID:
19492198
17.

The impact of fluorodeoxyglucose-positron emission tomography in primary staging and patient management in lymphoma patients.

Allen-Auerbach M, de Vos S, Czernin J.

Radiol Clin North Am. 2008 Mar;46(2):199-211, vii. doi: 10.1016/j.rcl.2008.03.004. Review.

PMID:
18619376
18.

The role of FDG PET in the management of lymphoma: what is the evidence base?

Kirby AM, Mikhaeel NG.

Nucl Med Commun. 2007 May;28(5):335-54. Review.

PMID:
17414883
19.

Utility of positron emission tomography (PET) scanning in managing patients with Hodgkin lymphoma.

Juweid ME.

Hematology Am Soc Hematol Educ Program. 2006:259-65, 510-1. Review.

PMID:
17124070
20.

PET monitoring of therapy response in head and neck squamous cell carcinoma.

Schöder H, Fury M, Lee N, Kraus D.

J Nucl Med. 2009 May;50 Suppl 1:74S-88S. doi: 10.2967/jnumed.108.057208. Epub 2009 Apr 20. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk